InnoCon Medical has in collaboration with Maastricht University Medical Center initiated a clinical study testing the UCon device in OAB patients, and in collaboration with Vall d’Hebron Barcelona Hospital, UCon is tested in patients with bowel disorders. We are excited to collaborate with these highly recognized and experienced sites, involving some of the leading clinicians within our field, bringing our device using Dorsal Genital Nerve Stimulation closer to market. Both sites have from the beginning shown great commitment, adding their experience in the study protocol design,  and we are looking forward to seeing more results from using our new technology.